NDA 075543 describes METOLAZONE, which is a drug marketed by
Alembic,
Ani Pharms,
Bayshore Pharms Llc,
Innogenix,
Mylan,
Ne Rx Pharma,
Renata,
Roxane,
Rubicon,
Sandoz, and
Watson Labs, and is included in twelve NDAs. It is available from
seventeen suppliers. Additional details are available on the
METOLAZONE profile page.
The generic ingredient in METOLAZONE is
metolazone. There are ten
drug master file entries for this compound. Seventeen
suppliers are listed for this compound. Additional details are available on the
metolazone profile page.